Login to Your Account

Other News To Note

Friday, February 25, 2011
Biovest International Inc., of Tampa, Fla., received a loan package of $1.5 million to establish a manufacturing site in Coon Rapids, Minn., for BiovaxID, its personalized cancer vaccine aimed at treating non-Hodgkin's lymphoma. The loan is being provided by the state of Minnesota, the city of Coon Rapids and real estate developer JMS Holdings LLC and is earmarked to support the initial expansion of Biovest's existing 35,000 square foot manufacturing facility to accommodate production for the cancer vaccine.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription